Simply Good Foods Repositions Atkins for GLP-1 Users

The company targets consumers exiting weight-loss drug treatments as sales for its flagship brand decline.

Updated on Oct. 28, 2026 in Weight Loss

Flat opaque gouache-painted editorial illustration of a fresh salad in a glass bowl, representing balanced healthy nutrition. — Simply Good Foods is refocusing its Atkins brand to provide weight-maintenance support for consumers transitioning off GLP-1 weight-loss medications. AI Illustration. Upload story photo >

Live Poll

Do you trust that consumer health brands can effectively help you manage weight after stopping GLP-1s?

Simply Good Foods is refocusing its Atkins brand to support individuals who have stopped taking GLP-1 weight-loss medications. This strategic pivot follows a year of financial decline and a significant drop in brand performance.

Why it matters

The company aims to address the common challenge of weight regain for former GLP-1 users, a cohort expected to grow as use of these medications expands nationwide. By pivoting, leadership seeks to stabilize revenue after missing financial expectations.

Simply Good Foods reported $1.4 billion in net sales for the 2026 fiscal year, a 6.5% decrease compared to the prior period. Atkins brand sales fell 20.9% during the same year.

The players

Simply Good Foods

This company is a nutritional food and snack manufacturer known for owning brands like Atkins and Owyn.

Joseph Scalzo

He returned as the CEO of Simply Good Foods in January 2026 to lead the company through a period of falling financial results.

Atkins

This is a brand of low-carbohydrate food products that was recently repositioned to attract consumers discontinuing weight-loss drugs.

The details

The firm redesigned the Atkins website to offer science-based educational content and increased investment in digital, social media, and influencer marketing campaigns. These changes aim to capture a market segment that may face the challenge of regaining up to two-thirds of lost weight after stopping GLP-1 prescriptions.

January 2026: Joseph Scalzo returned as CEO of Simply Good Foods.
2026 fiscal year: The company reported $1.4 billion in total net sales.
September 2026: The company launched a new marketing campaign.
October 2026: The company held an earnings call to announce the brand repositioning.

Health Landscape

The company is aligning its strategy with the trend toward 55 million projected GLP-1 users in the U.S. by 2035. This initiative seeks to bridge the gap in long-term weight management as the population of medication users continues to expand.

Individuals who have discontinued weight-loss medications may see an increase in targeted advertising and educational resources from the brand. This shift could impact how former users manage their nutritional routines and post-medication weight maintenance.

The takeaway

Consumers should prioritize professional medical advice when transitioning away from prescription weight-loss treatments to manage metabolic changes. Understanding the science of weight maintenance is essential for those navigating the period following the cessation of GLP-1 therapy.